First Report of Severe Autoimmune Hemolytic Anemia During Eltrombopag Therapy in Waldenström Macroglobulinemia-Associated Thrombocytopenia.

Shen, Yingying; Yu, Fanhua; Ge, Hangping; Shao, Keding; Zhou, Yuhong; Ye, Baodong; Shen, Yiping; Wu, Dijiong

Shen, Yingying; Yu, Fanhua; Ge, Hangping; Shao, Keding; Zhou, Yuhong; Ye, Baodong; Shen, Yiping; Wu, Dijiong.

Afiliação

Shen Y; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Yu F; Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Ge H; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Shao K; Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Zhou Y; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Ye B; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Shen Y; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
Wu D; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.

Onco Targets Ther ; 14: 5027-5033, 2021.

Article em En | MEDLINE | ID: mdl-34675547

Palavras-chave

Waldenström macroglobulinemia; eltrombopag; hemolytic anemia; ibrutinib; immune thrombocytopenia; rituximab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google